Award Number: W81XWH-10-1-0755 TITLE: Fibronectin Matrix Remodeling in the Regulation of the Inflammatory Response within the Lung: An Early Step in Lung Cancer Progression PRINCIPAL INVESTIGATOR:

Recent studies have pointed to changes in tissue mechanics as a contributory element to the development of malignancies. Increased tissue rigidity is associated with the unfolding of the Type III domains of fibronectin within the extracellular matrix. The consequences of this unfolding on cellular functions within the lung are not well understood. In the present study, we evaluated the effect of a peptide representing a partially unfolded intermediate of the first Type III repeat of fibronectin (FnIII-1c) on inflammatory gene expression in adult human lung fibroblast cells. FnIII-1c induced expression of cytokines, CXCL1-3, IL-8 and TNF-, by lung fibroblast cells. The increase in IL-8 expression was dependent on Toll-like receptor 2 and NFB. Immunohistochemistry of tissue arrays representing squamous cell carcinoma of the lung revealed extensive stromal staining for IL-8 and fibronectin fibrils which were co-aligned with myofibroblasts. These data suggest a model in which unfolding of FnIII domains secondary to myofibroblast-generated tension may induce the release of cytokines by stromal fibroblasts present within the lung tumor.

[1]  David M. Jones,et al.  The First Type III Domain of Fibronectin is Associated with the Expression of Cytokines within the Lung Tumor Microenvironment , 2011, Journal of Cancer.

[2]  P. McKeown-Longo,et al.  The First Type III Repeat in Fibronectin Activates an Inflammatory Pathway in Dermal Fibroblasts* , 2010, The Journal of Biological Chemistry.

[3]  A. MacKinnon,et al.  The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. , 2010, British medical bulletin.

[4]  A. Kho,et al.  Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression , 2010, The Journal of cell biology.

[5]  E. Abraham,et al.  Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? , 2010, Intensive Care Medicine.

[6]  K. Midwood,et al.  DAMPening Inflammation by Modulating TLR Signalling , 2010, Mediators of inflammation.

[7]  R. Dhir,et al.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. , 2010, Cancer research.

[8]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[9]  Lei Liu,et al.  Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion , 2010, BMC Cancer.

[10]  S. Rankin,et al.  CXCR2 Mediates the Recruitment of Endothelial Progenitor Cells During Allergic Airways Remodeling , 2009, Stem cells.

[11]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[12]  Gina Lee,et al.  Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer , 2009, Current opinion in pulmonary medicine.

[13]  P. McKeown-Longo,et al.  Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid Signaling , 2009, Molecular Cancer Research.

[14]  A. M. Houghton,et al.  Common origins of lung cancer and COPD , 2008, Nature Medicine.

[15]  Kristopher E Kubow,et al.  Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. , 2008, Faraday discussions.

[16]  J. Bai,et al.  Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549 , 2008, Cell biology international.

[17]  Ann Richmond,et al.  Role of chemokines in tumor growth. , 2007, Cancer letters.

[18]  Ying Zheng,et al.  Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. , 2007, American journal of respiratory cell and molecular biology.

[19]  D. Hocking,et al.  Identification of the Heparin-binding Determinants within Fibronectin Repeat III1 , 2006, Journal of Biological Chemistry.

[20]  J. Burger,et al.  CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells , 2005, Oncogene.

[21]  P. McKeown-Longo,et al.  Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells. , 2005, Cancer research.

[22]  P. McKeown-Longo,et al.  Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin , 2003, Journal of Cell Science.

[23]  M. Yi,et al.  A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.